The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: a single-centre retrospective analysis.
Saved in:
| Title: | The clinicopathological characteristics, oncologic outcomes and costs of "HER2-low" early breast cancer compared to HER2-zero and HER2-positive: a single-centre retrospective analysis. |
|---|---|
| Authors: | Rodrigues PR; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal., Lopes-Conceição L; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal., Sousa V; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.; Oncology Adult Day Hospital Unit, Portuguese Oncology Institute, Porto, Portugal., Coutada A; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal., Bento MJ; Epidemiology, Outcomes, Economics and Management in Oncology Group - Research Center (CI-IPOP), Porto Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.; Department of Population Studies, Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal., Coimbra N; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal., Leal C; Department of Anatomical Pathology, Portuguese Oncology Institute, Porto, Portugal., Pereira D; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal., Magalhães Ferreira A; Department of Medical Oncology, Portuguese Oncology Institute, Porto, Portugal.; Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 17; Vol. 15, pp. 1579602. Date of Electronic Publication: 2025 Sep 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
